Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Targeting the p53 pathway.

Golubovskaya VM, Cance WG.

Surg Oncol Clin N Am. 2013 Oct;22(4):747-64. doi: 10.1016/j.soc.2013.06.003. Review.

2.

Disruption of focal adhesion kinase and p53 interaction with small molecule compound R2 reactivated p53 and blocked tumor growth.

Golubovskaya VM, Ho B, Zheng M, Magis A, Ostrov D, Morrison C, Cance WG.

BMC Cancer. 2013 Jul 11;13:342. doi: 10.1186/1471-2407-13-342.

3.
4.

Drugging the p53 pathway: understanding the route to clinical efficacy.

Khoo KH, Verma CS, Lane DP.

Nat Rev Drug Discov. 2014 Mar;13(3):217-36. doi: 10.1038/nrd4236. Review. Erratum in: Nat Rev Drug Discov. 2014 Apr;13(4):314. Hoe, Khoo Kian [corrected to Khoo, Kian Hoe].

PMID:
24577402
5.

p53 Targeting can enhance cancer therapy via radiation, heat and anti-cancer agents.

Ohnishi T, Takahashi A, Mori E, Ohnishi K.

Anticancer Agents Med Chem. 2008 Jun;8(5):564-70. Review.

PMID:
18537537
6.

Focal adhesion kinase and p53 signaling in cancer cells.

Golubovskaya VM, Cance WG.

Int Rev Cytol. 2007;263:103-53. Review.

PMID:
17725966
7.

The p53 pathway as a target in cancer therapeutics: obstacles and promise.

Mandinova A, Lee SW.

Sci Transl Med. 2011 Jan 5;3(64):64rv1. doi: 10.1126/scitranslmed.3001366. Review.

8.

Targeting mutant p53 in human tumors.

Lehmann BD, Pietenpol JA.

J Clin Oncol. 2012 Oct 10;30(29):3648-50. doi: 10.1200/JCO.2012.44.0412. Review. No abstract available.

PMID:
22965952
9.

Heparin plays a key regulatory role via a p53/FAK-dependent signaling in melanoma cell adhesion and migration.

Chalkiadaki G, Nikitovic D, Berdiaki A, Katonis P, Karamanos NK, Tzanakakis GN.

IUBMB Life. 2011 Feb;63(2):109-19. doi: 10.1002/iub.421.

10.

14-3-3 zeta as novel molecular target for cancer therapy.

Matta A, Siu KW, Ralhan R.

Expert Opin Ther Targets. 2012 May;16(5):515-23. doi: 10.1517/14728222.2012.668185. Review.

PMID:
22512284
11.

Tissue-specific therapeutic targeting of p53 in cancer: one size does not fit all.

Vlatković N, Crawford K, Rubbi CP, Boyd MT.

Curr Pharm Des. 2011;17(6):618-30. Review.

PMID:
21391912
12.

[p53-regulating pathways as targets for personalized cancer therapy].

Höpker K, Reinhardt HC.

Dtsch Med Wochenschr. 2013 Jan;138(3):82-6. doi: 10.1055/s-0032-1327380. Review. German.

PMID:
23299342
13.

Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.

Shanthi E, Krishna MH, Arunesh GM, Venkateswara Reddy K, Sooriya Kumar J, Viswanadhan VN.

Expert Opin Ther Pat. 2014 Oct;24(10):1077-100. doi: 10.1517/13543776.2014.948845. Review.

PMID:
25113248
14.

Upregulation of periostin prevents P53-mediated apoptosis in SGC-7901 gastric cancer cells.

Li B, Wang L, Chi B.

Mol Biol Rep. 2013 Feb;40(2):1677-83. doi: 10.1007/s11033-012-2218-3.

PMID:
23076534
15.

Vertical pathway targeting in cancer therapy.

Shahbazian D, Sznol J, Kluger HM.

Adv Pharmacol. 2012;65:1-26. doi: 10.1016/B978-0-12-397927-8.00001-4. Review.

PMID:
22959021
16.

Targeting focal adhesion kinase signaling in tumor growth and metastasis.

Schwock J, Dhani N, Hedley DW.

Expert Opin Ther Targets. 2010 Jan;14(1):77-94. doi: 10.1517/14728220903460340. Review.

PMID:
20001212
17.

Modulating molecular functions of p53 with small molecules.

Mujtaba S, Zeng L, Zhou MM.

Cell Cycle. 2006 Nov;5(22):2575-8. Review.

PMID:
17172837
18.

Targeting receptor tyrosine kinases in solid tumors.

Zhang J, Hochwald SN.

Surg Oncol Clin N Am. 2013 Oct;22(4):685-703. doi: 10.1016/j.soc.2013.06.010. Review.

PMID:
24012395
19.

Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells.

Zhao J, Lu Y, Shen HM.

Cancer Lett. 2012 Jan 1;314(1):8-23. doi: 10.1016/j.canlet.2011.09.040. Review.

PMID:
22030255
20.

p53 family members in cancer diagnosis and treatment.

Machado-Silva A, Perrier S, Bourdon JC.

Semin Cancer Biol. 2010 Feb;20(1):57-62. doi: 10.1016/j.semcancer.2010.02.005. Review.

PMID:
20206267
Items per page

Supplemental Content

Support Center